Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivudine vs Famciclovir in Acute Herpes Zoster
NCT07099157Phase 4Recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Aug 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brivudine in herpes zoster (HZ), sponsored by Peking University Third Hospital. Started Aug 2025; status: recruiting.
02
Drugs
brivudine
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT07099157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07099157.